Nanosonics Ltd NNCSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.00
- Day Range
- $1.92–1.92
- 52-Week Range
- $1.77–3.22
- Bid/Ask
- $1.85 / $2.10
- Market Cap
- $581.72 Mil
- Volume/Avg
- 1,520 / 3,366
Key Statistics
- Price/Earnings (Normalized)
- 55.99
- Price/Sales
- 5.36
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics’ revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 400
- Website
- https://www.nanosonics.com.au
Competitors
Valuation
|
Metric
|
NNCSF
|
FPH
|
RMD
|
|---|---|---|---|
Price/Earnings (Normalized) | 55.99 | 89.90 | 28.36 |
Price/Book Value | 4.86 | 10.70 | 6.47 |
Price/Sales | 5.36 | 10.75 | 6.62 |
Price/Cash Flow | 36.80 | 44.00 | 23.81 |
Price/Earnings
NNCSF
FPH
RMD
Financial Strength
|
Metric
|
NNCSF
|
FPH
|
RMD
|
|---|---|---|---|
Quick Ratio | 5.26 | 0.88 | 1.32 |
Current Ratio | 6.56 | 1.83 | 3.04 |
Interest Coverage | 12.46 | 13.77 | 22.63 |
Quick Ratio
NNCSF
FPH
RMD
Profitability
|
Metric
|
NNCSF
|
FPH
|
RMD
|
|---|---|---|---|
Return on Assets (Normalized) | 9.04% | 11.54% | 15.75% |
Return on Equity (Normalized) | 11.94% | 15.07% | 24.94% |
Return on Invested Capital (Normalized) | 9.96% | 13.94% | 19.33% |
Return on Assets
NNCSF
FPH
RMD
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Dvhtnnsqb | Pny | $156.8 Bil | |||
| Becton Dickinson & Co
BDX
| Vrnntxfgf | Gpssyx | $68.6 Bil | |||
| Alcon Inc
ALC
| Jlbfzlqv | Fhpqwzg | $46.5 Bil | |||
| Coloplast A/S ADR
CLPBY
| Mdchpyqsx | Lkhj | $29.1 Bil | |||
| ResMed Inc
RMD
| Ydpszfmpkt | Rfzbpk | $28.9 Bil | |||
| West Pharmaceutical Services Inc
WST
| Qsfxyswb | Ypkd | $20.7 Bil | |||
| The Cooper Companies Inc
COO
| Ypjjzykd | Ptkblw | $18.6 Bil | |||
| Hologic Inc
HOLX
| Vqwqwhmf | Ncbnvm | $18.4 Bil | |||
| Baxter International Inc
BAX
| Kzylxjxg | Xmkvf | $18.1 Bil | |||
| Teleflex Inc
TFX
| Wkwzc | Pzvl | $10.4 Bil |